Head-to-head comparisons of medication uses, side effects, warnings, and more.
Imcivree (setmelanotide)
Zepbound (tirzepatide)
Imcivree (setmelanotide)
Zepbound (tirzepatide)
Summary of Imcivree vs. Zepbound
Summary for Melanocortin agonist
Prescription only
Imcivree (setmelanotide) is an injectable medication for people over the age of 2 with certain rare genetic conditions. It's FDA approved to help with obesity in people with Bardet-Biedl syndrome (BBS). It can also help with obesity in people with POMC, PCSK1, or LEPR deficiency. Imcivree (setmelanotide) works as a melanocortin agonist. It lessens appetite and makes the body use up more energy, which leads to weight loss. This medication is injected under the skin once a day. Side effects include injection site reactions and nausea. There are also serious risks of depression and suicidal thoughts.
Summary for GIP and GLP-1 agonist
Prescription only
Zepbound (tirzepatide) is an injectable medication that's used along with diet and exercise. It helps with weight loss in adults who meet criteria for weight management therapy. It's also approved to treat moderate-to-severe sleep apnea. This medication belongs to the drug class called GIP and GLP-1 agonists. The dosage is 1 injection under the skin once a week. Common side effects include nausea, diarrhea, and injection site reactions. Zepbound (tirzepatide) is only available as a brand-name medication.
Indications of Imcivree vs. Zepbound
Indications for
•Long-term weight management in people ages 2 years and older with obesity due to certain genetic conditions: